Page last updated: 2024-09-04

levofloxacin and Graft-Versus-Host Disease

levofloxacin has been researched along with Graft-Versus-Host Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Courter, JD; Dandoy, CE; Davies, SM; Gardner, JC; Teusink-Cross, A1
Kaufmann, M; Knabbe, C; Seibold, E; Splettstoesser, W; Weile, J1
Chang, FY; Chang, PY; Chao, TY; Chen, YC; Dai, MS; Ho, CL; Kao, WY; Lin, JC; Wang, CH; Wu, YY1
Bateman, AC; Clarridge, J; Garvin, K; Greenbaum, A; Grim, J; Liu, AW1

Other Studies

4 other study(ies) available for levofloxacin and Graft-Versus-Host Disease

ArticleYear
Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients.
    Transplantation and cellular therapy, 2022, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Child; Child, Preschool; Clostridium Infections; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Levofloxacin; Retrospective Studies; Young Adult

2022
Treatment of tularemia in patient with chronic graft-versus-host disease.
    Emerging infectious diseases, 2013, Volume: 19, Issue:5

    Topics: Anti-Bacterial Agents; Chronic Disease; Doxycycline; Francisella tularensis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Tularemia

2013
Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:1

    Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Drug Resistance, Multiple, Bacterial; Female; Graft vs Host Disease; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Risk Factors; Taiwan; Transplant Recipients; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Young Adult

2018
Cutaneous phaeohyphomycosis in a hematopoietic stem cell transplant patient caused by Alternaria rosae: First case report.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:3

    Topics: Acute Kidney Injury; Acyclovir; Aged; Alternaria; Alternariosis; Antibiotic Prophylaxis; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Graft vs Host Disease; Hand; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Levofloxacin; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Paranasal Sinuses; Phaeohyphomycosis; Pneumonia; Prednisone; Primary Myelofibrosis; Respiratory Insufficiency; Spores, Fungal; Transplantation, Homologous; Triazoles; Voriconazole

2017